Association of Serum Adropin Concentrations with Diabetic Nephropathy

Abstract EN

Objective.

Adropin is a newly identified regulatory protein encoded by the Enho gene and is critically involved in energy homeostasis and insulin sensitivity.

This study aims to determine the correlation of serum adropin concentrations with diabetic nephropathy (DN).

Methods.

This study consisted of 245 patients with type 2 diabetes mellitus (T2DM) and 81 healthy subjects.

Then T2DM patients were divided into normoalbuminuria, microalbuminuria, and macroalbuminuria subgroups based on urine albumin to creatinine ratio (ACR).

Results.

T2DM patients showed significantly lower serum adropin concentrations than those in the controls.

T2DM patients with macroalbuminuria had significantly decreased serum adropin concentrations compared with the other three groups.

In addition, T2DM patients with microalbuminuria showed lower serum adropin concentrations than those in patients with normoalbuminuria.

Logistic regression analysis showed that serum adropin was correlated with decreased risk of developing T2DM and DN.

Pearson correlation analysis indicated that serum adropin was negatively correlated with body mass index (BMI), blood urea nitrogen, creatinine, and ACR and positively correlated with glomerular filtration rate.

Furthermore, multiple linear regression analysis showed that BMI and ACR were negatively correlated with serum adropin levels.

Conclusion.

Serum adropin concentrations are negatively associated with renal function.

Adropin may be implicated in the pathogenesis of DN development.